Casdin Capital, LLC Denali Therapeutics Inc. Transaction History

Casdin Capital, LLC

  • $1.29 Billion
  • Q3 2024

A detailed history of Casdin Capital, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 990,000 shares of DNLI stock, worth $23.9 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
990,000
Previous 1,300,000 23.85%
Holding current value
$23.9 Million
Previous $30.2 Million 4.47%
% of portfolio
2.24%
Previous 2.6%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$20.96 - $31.05 $6.5 Million - $9.63 Million
-310,000 Reduced 23.85%
990,000 $28.8 Million
Q4 2022

Feb 14, 2023
BUY
$26.28 - $33.92 $8.02 Million - $10.3 Million
305,000 Added 30.65%
1,300,000 $36.2 Million
Q3 2022

Nov 14, 2022
SELL
$25.97 - $38.53 $13.1 Million - $19.5 Million
-505,000 Reduced 33.67%
995,000 $30.5 Million
Q4 2021

Feb 14, 2022
SELL
$42.59 - $55.02 $8.52 Million - $11 Million
-200,000 Reduced 11.76%
1,500,000 $66.9 Million
Q3 2021

Nov 15, 2021
BUY
$48.48 - $78.23 $4.36 Million - $7.04 Million
90,000 Added 5.59%
1,700,000 $85.8 Million
Q1 2021

May 17, 2021
BUY
$53.8 - $81.53 $16.1 Million - $24.5 Million
300,000 Added 22.9%
1,610,000 $91.9 Million
Q2 2020

Aug 14, 2020
SELL
$16.01 - $28.82 $2.32 Million - $4.18 Million
-145,000 Reduced 9.97%
1,310,000 $31.7 Million
Q1 2020

May 15, 2020
BUY
$14.2 - $27.98 $2.91 Million - $5.74 Million
205,000 Added 16.4%
1,455,000 $25.5 Million
Q4 2019

Feb 14, 2020
BUY
$14.4 - $19.99 $8.64 Million - $12 Million
600,000 Added 92.31%
1,250,000 $21.8 Million
Q3 2019

Jan 03, 2020
BUY
$15.32 - $21.92 $3.83 Million - $5.48 Million
250,000 Added 62.5%
650,000 $9.96 Billion
Q3 2019

Nov 12, 2019
SELL
$15.32 - $21.92 $3.83 Million - $5.48 Million
-250,000 Reduced 38.46%
400,000 $8.3 Billion
Q3 2019

Nov 12, 2019
BUY
$15.32 - $21.92 $3.83 Million - $5.48 Million
250,000 Added 62.5%
650,000 $9.96 Billion
Q2 2019

Aug 13, 2019
BUY
$18.5 - $28.14 $5.55 Million - $8.44 Million
300,000 Added 300.0%
400,000 $0
Q4 2018

Feb 13, 2019
BUY
$13.88 - $21.75 $1.39 Million - $2.18 Million
100,000 New
100,000 $2.07 Million

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.24B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email